- Home
- GRCE vs UTSI Comparison
GRCE vs UTSI Comparison
Compare GRCE & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- UTSI
- Stock Information
- Founded
- GRCE 2002
- UTSI 1991
- Country
- GRCE United States
- UTSI China
- Employees
- GRCE N/A
- UTSI N/A
- Industry
- GRCE
- UTSI Telecommunications Equipment
- Sector
- GRCE
- UTSI Telecommunications
- Exchange
- GRCE NYSE
- UTSI Nasdaq
- Market Cap
- GRCE 42.4M
- UTSI 24.9M
- IPO Year
- GRCE N/A
- UTSI 2000
- Fundamental
- Price
- GRCE $3.35
- UTSI $2.45
- Analyst Decision
- GRCE Strong Buy
- UTSI
- Analyst Count
- GRCE 1
- UTSI 0
- Target Price
- GRCE $12.00
- UTSI N/A
- AVG Volume (30 Days)
- GRCE 63.7K
- UTSI 7.1K
- Earning Date
- GRCE 08-15-2025
- UTSI 09-04-2025
- Dividend Yield
- GRCE N/A
- UTSI N/A
- EPS Growth
- GRCE N/A
- UTSI N/A
- EPS
- GRCE N/A
- UTSI N/A
- Revenue
- GRCE N/A
- UTSI $10,878,000.00
- Revenue This Year
- GRCE N/A
- UTSI N/A
- Revenue Next Year
- GRCE N/A
- UTSI N/A
- P/E Ratio
- GRCE N/A
- UTSI N/A
- Revenue Growth
- GRCE N/A
- UTSI N/A
- 52 Week Low
- GRCE $1.75
- UTSI $1.84
- 52 Week High
- GRCE $4.97
- UTSI $3.22
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- UTSI 46.74
- Support Level
- GRCE N/A
- UTSI $2.65
- Resistance Level
- GRCE N/A
- UTSI $2.79
- Average True Range (ATR)
- GRCE 0.00
- UTSI 0.12
- MACD
- GRCE 0.00
- UTSI 0.00
- Stochastic Oscillator
- GRCE 0.00
- UTSI 4.35
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.